Testimonies & Filings

Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".
May 24, 2016
While the FTC has long provided valuable oversight and protection, there is an opportunity for Congress to modernize the agency to better protect consumers and better enable innovation.
May 24, 2016
The distinction between employees and independent contractors is discouraging companies from offering gig economy workers important support.
May 11, 2016
The U.S. must go beyond funding R&D to ensure that more of the public investment in knowledge creation translates into innovation and jobs.
April 21, 2016
ITIF examines USDA's proposals and notes where they are consistent with U.S. policy and the White House Office of Science and Technology Policy's mandate and where they are not.
April 19, 2016
ITIF wrote a letter in support of funds to better inform the public about the application of biotechnology to food and agricultural production.
March 25, 2016
In comments to the White House on draft data security policies for the Precision Medicine Initiative, ITIF’s Center for Data Innovation explains why de-identification is an effective and reliable tool for safeguarding sensitive data.
March 22, 2016
ITIF’s Center for Data Innovation submitted comments to the U.S. National Institute for Occupational Safety and Health on how the Internet of Things can improve the efficiency and effectiveness of emergency response efforts.
March 21, 2016
ITIF submitted comments to the U.S. Copyright Office on how it can update the notice-and-takedown process for illegal content to better balance the rights of copyright owners, online service providers, and users, as well as reduce online infringement.
March 1, 2016
In testimony to the Boulder County Commission, Val Giddings said it is the best way to safely meet their established sustainability goals to the benefit of consumers, farmers, and the environment.
February 15, 2016
In testimony to the U.S. ITC, Stephen Ezell explains why biotech is a key driver of both the U.S. economy and global life sciences innovation, and he argues robust IP standards in the TPP will be critical to both.

Pages